Literature DB >> 2007359

Pathogenetic role of Helicobacter pylori in duodenal ulcer disease. Multivariate analysis of factors affecting relapse.

W M Hui1, J Ho, S K Lam.   

Abstract

The pathogenesis of duodenal ulcer disease is multifactorial and the contribution of Helicobacter pylori in relation to the other factors to the release of duodenal ulcer is unknown. To investigate this, we studied 147 patients with endoscopically proven healed ulcers. These patients were randomized to receive either placebo, misoprostol 200 micrograms or misoprostol 300 micrograms four times daily, and clinical, personal, physiological and endoscopic characteristics were obtained prospectively. Endoscopy was performed at the active phase of the ulcer and when the ulcer healed. Biopsies were taken from the antrum to assess histologically for: (1) the activity of gastritis as assessed by the degree of polymorph infiltration, (2) the degree of chronic inflammation by the degree of chronic inflammatory cells infiltration and degree of mucosal degeneration, and (3) bacteriologically for the presence of H. pylori. The severity of the gastritis and the bacterial density were graded independently by two pathologists. The patients were assessed at two-month intervals for 12 months or until the ulcer relapsed. The results demonstrated that the relapse rates of duodenal ulcer were similar in the three treatment groups. The relapse rate was higher in the group with higher density of the bacteria (P less than 0.05). The degree of gastritis did not affect the relapse rate of duodenal ulcer in either the placebo or misoprostol group or in all patients combined. Stepwise logistic regression analysis identified that increased duodenal inflammation, male sex, early-onset disease, and H. pylori adversely affected relapse of the ulcer. We conclude that multiple factors affect the relapse of duodenal ulcer and H. pylori is one of them.

Entities:  

Mesh:

Year:  1991        PMID: 2007359     DOI: 10.1007/bf01298869

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1.

Authors:  W M Hui; S K Lam; J Ho; M M Ng; I Lui; C L Lai; A S Lok; W Y Lau; G P Poon; S Choi
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

2.  Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.

Authors:  S K Lam; W Y Lau; T K Choi; C L Lai; A S Lok; W M Hui; M M Ng; S K Choi
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

3.  Immune response to Campylobacter pyloridis in patients with peptic ulceration.

Authors:  J Kaldor; W Tee; P McCarthy; J Watson; B Dwyer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

4.  A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.

Authors:  S P Lee
Journal:  Scand J Gastroenterol Suppl       Date:  1982

5.  Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.

Authors:  F I Lee; I M Samloff; M Hardman
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

6.  Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.

Authors:  A B Price; J Levi; J M Dolby; P L Dunscombe; A Smith; J Clark; M L Stephenson
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

7.  Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.

Authors:  I Hamilton; H J O'Connor; N C Wood; I Bradbury; A T Axon
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

8.  Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis.

Authors:  W M Hui; S K Lam; P Y Chau; J Ho; I Lui; C L Lai; A S Lok; M M Ng
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

9.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

10.  Predictors of duodenal ulcer healing and relapse.

Authors:  A Sonnenberg; S A Müller-Lissner; E Vogel; P Schmid; J J Gonvers; P Peter; G Strohmeyer; A L Blum
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

View more
  7 in total

1.  Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding.

Authors:  Benito Velayos; Luis Fernández-Salazar; Fernando Pons-Renedo; María F Muñoz; Ana Almaraz; Rocío Aller; Lourdes Ruíz; Lourdes Del Olmo; Javier P Gisbert; José M González-Hernández
Journal:  Dig Dis Sci       Date:  2012-03-28       Impact factor: 3.199

2.  High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.

Authors:  M Moshkowitz; F M Konikoff; Y Peled; M Santo; A Hallak; Y Bujanover; E Tiomny; T Gilat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

3.  One week's anti-Helicobacter pylori treatment for duodenal ulcer.

Authors:  R P Logan; P A Gummett; J J Misiewicz; Q N Karim; M M Walker; J H Baron
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 4.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

5.  Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori.

Authors:  D G Evans; T K Karjalainen; D J Evans; D Y Graham; C H Lee
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

Review 6.  Helicobacter pylori, peptic ulcer and gastric cancer in China.

Authors:  S K Lam; B C Wong
Journal:  Yale J Biol Med       Date:  1998 Jan-Feb

7.  What is the best method to diagnose Helicobacter infection in bleeding peptic ulcers?: a prospective trial.

Authors:  I K Chung; S J Hong; E J Kim; J Y Cho; H S Kim; S H Park; M H Lee; S J Kim; C S Shim
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.